BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18677536)

  • 1. The cost-effectiveness of three strategies for the surgical treatment of symptomatic primary hyperparathyroidism.
    Baliski C; Nosyk B; Melck A; Bugis S; Rosenberg F; H Anis A
    Ann Surg Oncol; 2008 Oct; 15(10):2653-60. PubMed ID: 18677536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of screening for synchronous thyroid disease in patients presenting with primary hyperparathyroidism.
    Hollenbeak CS; Lendel I; Beus KS; Ruda JM; Stack BC
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1013-21. PubMed ID: 17938325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis.
    Sejean K; Calmus S; Durand-Zaleski I; Bonnichon P; Thomopoulos P; Cormier C; Legmann P; Richard B; Bertagna XY; Vidal-Trecan GM
    Eur J Endocrinol; 2005 Dec; 153(6):915-27. PubMed ID: 16322399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery versus Imaging in Non-Localizing Primary Hyperparathyroidism: A Cost-Effectiveness Model.
    Frank E; Watson W; Fujimoto S; De Andrade Filho P; Inman J; Simental A
    Laryngoscope; 2020 Dec; 130(12):E963-E969. PubMed ID: 32065406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroidectomy in a district general hospital: outcomes and evolution in the era of minimally invasive surgery.
    Paravastu SC; Chadwick DR
    Int J Surg; 2012; 10(7):373-7. PubMed ID: 22691548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism.
    Zanocco K; Angelos P; Sturgeon C
    Surgery; 2006 Dec; 140(6):874-81; discussion 881-2. PubMed ID: 17188133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis.
    Zanocco K; Sturgeon C
    Surgery; 2008 Aug; 144(2):290-8. PubMed ID: 18656638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocalcemia after neck exploration for untreated primary hyperparathyroidism.
    Conn CA; Clark J; Bumpous J; Goldstein R; Fleming M; Flynn MB
    Am Surg; 2006 Dec; 72(12):1234-7. PubMed ID: 17216827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial.
    Westerdahl J; Bergenfelz A
    Ann Surg; 2007 Dec; 246(6):976-80; discussion 980-1. PubMed ID: 18043099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year financial analysis of minimally invasive radio-guided parathyroidectomy.
    Hutchinson JR; Yandell DW; Bumpous JM; Fleming MM; Flynn MB
    Am Surg; 2004 Dec; 70(12):1112-5. PubMed ID: 15663056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model.
    Fiddelers AA; Dirksen CD; Dumoulin JC; van Montfoort AP; Land JA; Janssen JM; Evers JL; Severens JL
    Hum Reprod; 2009 Jul; 24(7):1648-55. PubMed ID: 19318703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operative treatment of primary hyperparathyroidism: balancing cost-effectiveness with successful outcomes.
    Elaraj D; Sturgeon C
    Surg Clin North Am; 2014 Jun; 94(3):607-23. PubMed ID: 24857579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted parathyroidectomy: effectiveness and intraoperative rapid-parathormone dynamics.
    Sadeghi N; Akin E; Lee JY; Roland J; Knoll S
    Laryngoscope; 2008 Nov; 118(11):1997-2002. PubMed ID: 18849859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The actual role of bilateral neck exploration in the treatment of primary hyperparathyroidism].
    Bellotti C; Capponi MG; Cancrini G; Mezzetti G; Scicchitano F; Talamao N; Cancrini A
    G Chir; 2006 Apr; 27(4):179-82. PubMed ID: 16768876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of additional preoperative ultrasonography or sestamibi-SPECT in patients with primary hyperparathyroidism and negative findings on sestamibi scans.
    Ruda JM; Stack BC; Hollenbeak CS
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):46-53. PubMed ID: 16415429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Parathyroidectomy in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis.
    Singh Ospina NM; Rodriguez-Gutierrez R; Maraka S; Espinosa de Ycaza AE; Jasim S; Castaneda-Guarderas A; Gionfriddo MR; Al Nofal A; Brito JP; Erwin P; Richards M; Wermers R; Montori VM
    World J Surg; 2016 Oct; 40(10):2359-77. PubMed ID: 27094563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive parathyroidectomy: use of intraoperative parathyroid hormone assays after 2 preoperative localization studies.
    Smith N; Magnuson JS; Vidrine DM; Kulbersh B; Peters GE
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1108-11. PubMed ID: 19917923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of scan-directed parathyroidectomy.
    Mihai R; Weisters M; Stechman MJ; Gleeson F; Sadler G
    Langenbecks Arch Surg; 2008 Sep; 393(5):739-43. PubMed ID: 18670746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive parathyroidectomy as treatment for primary hyperparathyroidism.
    Giraldez-Rodriguez LA; Giraldez-Casasnovas LJ
    Bol Asoc Med P R; 2008; 100(1):27-32. PubMed ID: 18763394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.